Abstract:Rationale: Pulmonary arterial hypertension (PAH) is characterized by progressive increase of pulmonary vascular resistance and pulmonary vascular remodeling that result in right heart failure. Published studies show that recessive mutations in the EIF2AK4 gene (encoding GCN2, General control nonderepressibe 2 kinase) resulting in reduction of GCN2 are linked to heritable pulmonary veno-occlusive disease (PVOD) in patients and EIF2AK4 mutation was also found in PAH patients although very rare. Objective: To determine the role of endothelial GCN2 kinase in the pathogenesis of PAH. Results: Employing Eif2ak4 -/- mice, we found that loss of GCN2 induced neither spontaneous PVOD nor pulmonary hypertension (PH). In response to chronic hypoxia, loss of GCN2 inhibited hypoxia-induced PH and pulmonary vascular remodeling. RNA-sequencing analysis of mouse lung samples indicated Endothelin-1 as the downstream target of GCN2 in regulating pulmonary vascular remodeling and PH. In cultured human lung microvascular endothelial cells, GCN2 was phosphorylated and activated in response to hypoxia, which mediated hypoxia-induced Endothelin-1 expression through the GCN2/ATF4/HIF-2a/Endothelin-1 pathway. Endothelial cell-targeted nanoparticle delivery of plasmid DNA expressing Endothelin-1 selectively in endothelial cells in Eif2ak4 -/- mice markedly reversed the phenotype in response to hypoxia. Furthermore, nanoparticle delivery of the CRIPSR/Cas9 system-mediated knockout of Eif2ak4 in adult C57BL/6 mice also attenuated hypoxia-induced PH. Additionally, monocrotaline-induced vascular remodeling and PH in rats were inhibited by GCN2 inhibitor A-92 treatment. In lung samples of idiopathic PAH patients, we observed endothelial GCN2 hyperphosphorylation of pulmonary vascular lesions, without marked differences in GCN2 mRNA and protein levels compared to normal donor lungs. Conclusion: These studies demonstrate that endothelial GCN2 activation mediates pulmonary vascular remodeling and PAH development through the GCN2/ATF4/HIF-2a/Endothelin-1 pathway. Targeting GCN2 signaling is a promising therapeutic strategy for treatment of PAH in patients without GCN2 loss of function mutations.

EIF2AK4 Mutation in Pulmonary Veno-Occlusive Disease

Rapid disease progress in a PVOD patient carrying a novel EIF 2 AK 4 mutation: a case report

Rapid disease progress in a PVOD patient carrying a novel EIF<sub>2</sub>AK<sub>4</sub>mutation: a case report

Identification of a Novel Mutation in the BMPR2 Gene in a Pulmonary Arterial Hypertension Patient Using Next‐generation Sequencing

[Clinical Characteristics and Survival of Patients with Pulmonary Veno-Occlusive Disease].

Pulmonary veno‐occlusive disease: A systematic review of risk factors, clinical presentation, diagnostic investigations, treatment outcomes and prognostic factors

[Pulmonary Veno-Occlusive Disease/pulmonary Capillary Hemangiomatosis: A Case Report and Literature Review].

Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report

Pulmonary veno-occlusive disease: illustrative cases and literature review

Synchrotron‐Based Phase‐Contrast Micro‐CT Combined With Histology to Decipher Differences Between Hereditary and Sporadic Pediatric Pulmonary Veno‐Occlusive Disease

Lengthy Diagnostic Challenge In A Rare Case Of Pulmonary Veno-Occlusive Disease: Case Report And Review Of The Literature

GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease

[Clinical and imaging features of pulmonary veno-occlusive disease and pulmonary capillary hemangioma].

Case report of a young male, with recurrent pneumothorax, hemoptysis and intrapulmonary cavitary lesions

Abstract 17370: Activation of Endothelial GCN2 Kinase Contributes to Pulmonary Vascular Remodeling and Pulmonary Arterial Hypertension

Functional validation of EIF2AK4 (GCN2) missense variants associated with pulmonary arterial hypertension

SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension.

Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response

A Novel Mutation in the BMPR2 Gene in Familial Pulmonary Arterial Hypertension

Identification and Functional Characterization of a Novel Surfactant Protein A2 Mutation (p.n207y) in a Chinese Family with Idiopathic Pulmonary Fibrosis

Mechanisms underlying age-associated exacerbation of pulmonary veno-occlusive disease